🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

RxSight, Inc.

RXST Healthcare
$5.08 +$0.18 (3.67%)
Market Cap: $211.29 M
Gurus Holding
5
Popularity Rank
#1819
% of Shares Held
6.58%
Net Activity (Q2 2026)
+$5.23 M

Guru Ownership Trend

Guru Analysis for RxSight, Inc. (RXST)

RxSight, Inc. (RXST), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.9 M.

Top institutional holders include Cliff Asness and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $5.23 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 141.1%. Conversely, Paul Tudor Jones reduced exposure by 12.7%.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$5.32 M
Total Buy Value
New Buys 0
Additions 4
-$92,659.75
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for RxSight, Inc. (RXST)

Major holders include Cliff Asness ($7.39 M), Steven Cohen ($3.75 M), Louis Moore Bacon ($730,230). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.74 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.23 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited RXST. The total reported sell value was $92,659.75.

Yes, 0 managers opened new positions in RXST, and 4 increased their existing holdings. The total reported buy value was $5.32 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 141.1% 1,533,826 $7.39 M Q2 2026
0.00% Add 6.1% 778,252 $3.75 M Q2 2026
0.01% Add 116.2% 151,500 $730,230 Q2 2026
0.00% Add 132.9% 140,693 $678,140 Q2 2026
0.00% Reduce -12.7% 131,736 $634,968 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form